Published in J Clin Oncol on February 08, 2010
An animal model of MYC-driven medulloblastoma. Cancer Cell (2012) 2.12
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. J Clin Oncol (2015) 1.72
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43
Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol (2010) 1.09
Childhood brain tumors: epidemiology, current management and future directions. Nat Rev Neurol (2011) 1.09
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease. Cancer Cell (2014) 1.08
Molecular subgroups of medulloblastoma. Expert Rev Neurother (2012) 1.05
Molecular diagnostics in embryonal brain tumors. Brain Pathol (2011) 1.00
p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol (2011) 0.98
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro Oncol (2012) 0.97
p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer. Genes Cancer (2011) 0.96
TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas. J Clin Oncol (2011) 0.96
The rationale for targeted therapies in medulloblastoma. Neuro Oncol (2013) 0.92
Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients. Clin Cancer Res (2014) 0.90
Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? Neuro Oncol (2015) 0.89
WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma. Oncogene (2016) 0.87
Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors. Pediatr Blood Cancer (2013) 0.87
Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features. BMC Cancer (2014) 0.85
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions. Mol Diagn Ther (2013) 0.85
ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma. Exp Hematol Oncol (2013) 0.84
PCDH10 is a candidate tumour suppressor gene in medulloblastoma. Childs Nerv Syst (2011) 0.84
Matching mice to malignancy: molecular subgroups and models of medulloblastoma. Childs Nerv Syst (2012) 0.83
Hereditary ovarian cancer: not only BRCA 1 and 2 genes. Biomed Res Int (2015) 0.81
HDM2 promotes WIP1-mediated medulloblastoma growth. Neuro Oncol (2012) 0.81
Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol (2013) 0.81
Inhibitory effects of epigenetic modulators and differentiation inducers on human medulloblastoma cell lines. J Exp Clin Cancer Res (2013) 0.81
WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma. Neurosurgery (2012) 0.81
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? PLoS One (2014) 0.79
Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors. Acta Neuropathol Commun (2014) 0.78
MADM-ML, a mouse genetic mosaic system with increased clonal efficiency. PLoS One (2013) 0.78
Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions. In Vivo (2012) 0.78
MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties. BMC Cancer (2016) 0.78
Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells. PLoS One (2014) 0.77
Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells. Biochem Biophys Res Commun (2014) 0.77
Identification of 2R-ohnologue gene families displaying the same mutation-load skew in multiple cancers. Open Biol (2014) 0.77
Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline. Clin Neuropathol (2016) 0.76
Neuroradiology and histopathology in two cases of adult medulloblastoma. Neuroradiol J (2014) 0.75
Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway. Cancer Res (2016) 0.75
Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs. J Exp Clin Cancer Res (2016) 0.75
The diploid genome sequence of an individual human. PLoS Biol (2007) 44.80
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
International network of cancer genome projects. Nature (2010) 20.35
Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature (2012) 10.99
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06
Genome assembly comparison identifies structural variants in the human genome. Nat Genet (2006) 6.93
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
PreBIND and Textomy--mining the biomedical literature for protein-protein interactions using a support vector machine. BMC Bioinformatics (2003) 6.31
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell (2012) 6.07
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol (2006) 5.96
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet (2009) 4.52
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol (2012) 4.00
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature (2010) 3.70
Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol (2006) 3.68
Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol (2010) 3.51
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol (2011) 3.33
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol (2014) 3.21
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell (2011) 3.11
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res (2009) 3.03
Medulloblastomics: the end of the beginning. Nat Rev Cancer (2012) 3.01
Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature (2012) 2.96
Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) 2.95
Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol (2009) 2.95
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med (2011) 2.93
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol (2013) 2.82
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell (2013) 2.74
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev (2009) 2.58
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol (2011) 2.53
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell (2012) 2.45
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet (2013) 2.42
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol (2013) 2.34
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol (2012) 2.34
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci U S A (2008) 2.22
Genetic analysis of patients with the Saethre-Chotzen phenotype. Am J Med Genet (2002) 2.17
An animal model of MYC-driven medulloblastoma. Cancer Cell (2012) 2.12
The clinical implications of medulloblastoma subgroups. Nat Rev Neurol (2012) 2.12
Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol (2004) 2.07
Adult medulloblastoma comprises three major molecular variants. J Clin Oncol (2011) 2.07
PhenoTips: patient phenotyping software for clinical and research use. Hum Mutat (2013) 2.04
Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas. Neuro Oncol (2009) 2.04
Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma. J Neurosurg (2014) 2.02
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol (2011) 2.01
Analysis of the glucocerebrosidase gene in Parkinson's disease. Mov Disord (2005) 1.99
Identifying genes regulated in a Myc-dependent manner. J Biol Chem (2002) 1.98
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell (2009) 1.92
Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol (2012) 1.92
The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell (2003) 1.90
Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol (2012) 1.88
Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol (2010) 1.88
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol (2011) 1.85
Pleiotropic role for MYCN in medulloblastoma. Genes Dev (2010) 1.84
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol (2010) 1.83
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res (2010) 1.81
Grandpa and I have dystrophinopathy?: approach to asymptomatic hyperCKemia. Pediatr Neurol (2006) 1.78
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78
OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Cancer Res (2009) 1.77
Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization. Oncogene (2004) 1.77
MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One (2009) 1.73
Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol (2005) 1.71
Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol (2010) 1.70
Diffuse intrinsic brainstem tumors in neonates. Report of two cases. J Neurosurg Pediatr (2008) 1.69
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol (2013) 1.68
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol (2010) 1.66
A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Am J Hum Genet (2013) 1.66
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev (2012) 1.64
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol (2011) 1.64
Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum Mol Genet (2003) 1.60
Copy number variations and cancer. Genome Med (2009) 1.59
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56